By 2004, major malaria vectors and other possible vectors of malaria had developed metabolic resistance with increased activity of esterases, GSTs and monooxygenases, and altered acetylcholinesterases (acetylcholinesterase is the target site of organophosphates and carbamates) and kdr type resistance [43,55]. The gene discussed is ACHE; the disease is malaria.